Terms: = Head and neck cancer AND KAT6B, DKFZp313G1618, 23522, MYST4, ENSG00000156650, Q8WYB5, querkopf, qkf, MOZ2, MORF, KIAA0383, FLJ90335 AND Clinical Outcome
1 results:
1. miR-22/kat6b axis is a chemotherapeutic determiner via regulation of PI3k-Akt-NF-kB pathway in tongue squamous cell carcinoma.
Gu Y; Liu H; Kong F; Ye J; Jia X; Zhang Z; Li N; Yin J; Zheng G; He Z
J Exp Clin Cancer Res; 2018 Jul; 37(1):164. PubMed ID: 30041677
[TBL] [Abstract] [Full Text] [Related]
